IBDEI0IW ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8784,1,4,0)
 ;;=4^T85.398A
 ;;^UTILITY(U,$J,358.3,8784,2)
 ;;=^5055559
 ;;^UTILITY(U,$J,358.3,8785,0)
 ;;=T86.840^^41^468^58
 ;;^UTILITY(U,$J,358.3,8785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8785,1,3,0)
 ;;=3^Corneal Transplant Rejection
 ;;^UTILITY(U,$J,358.3,8785,1,4,0)
 ;;=4^T86.840
 ;;^UTILITY(U,$J,358.3,8785,2)
 ;;=^5055744
 ;;^UTILITY(U,$J,358.3,8786,0)
 ;;=T86.841^^41^468^57
 ;;^UTILITY(U,$J,358.3,8786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8786,1,3,0)
 ;;=3^Corneal Transplant Failure
 ;;^UTILITY(U,$J,358.3,8786,1,4,0)
 ;;=4^T86.841
 ;;^UTILITY(U,$J,358.3,8786,2)
 ;;=^5055745
 ;;^UTILITY(U,$J,358.3,8787,0)
 ;;=T85.318A^^41^468^22
 ;;^UTILITY(U,$J,358.3,8787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8787,1,3,0)
 ;;=3^Breakdown of Ocular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,8787,1,4,0)
 ;;=4^T85.318A
 ;;^UTILITY(U,$J,358.3,8787,2)
 ;;=^5055541
 ;;^UTILITY(U,$J,358.3,8788,0)
 ;;=T85.328A^^41^468^59
 ;;^UTILITY(U,$J,358.3,8788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8788,1,3,0)
 ;;=3^Displacement of Ocular Prosthetic Device/Implant/Graft,Init Encntr
 ;;^UTILITY(U,$J,358.3,8788,1,4,0)
 ;;=4^T85.328A
 ;;^UTILITY(U,$J,358.3,8788,2)
 ;;=^5055550
 ;;^UTILITY(U,$J,358.3,8789,0)
 ;;=H11.013^^41^468^2
 ;;^UTILITY(U,$J,358.3,8789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8789,1,3,0)
 ;;=3^Amyloid Pterygium,Bilateral
 ;;^UTILITY(U,$J,358.3,8789,1,4,0)
 ;;=4^H11.013
 ;;^UTILITY(U,$J,358.3,8789,2)
 ;;=^5004722
 ;;^UTILITY(U,$J,358.3,8790,0)
 ;;=H21.513^^41^468^6
 ;;^UTILITY(U,$J,358.3,8790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8790,1,3,0)
 ;;=3^Anterior Synechiae,Bilateral
 ;;^UTILITY(U,$J,358.3,8790,1,4,0)
 ;;=4^H21.513
 ;;^UTILITY(U,$J,358.3,8790,2)
 ;;=^5005241
 ;;^UTILITY(U,$J,358.3,8791,0)
 ;;=H18.423^^41^468^12
 ;;^UTILITY(U,$J,358.3,8791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8791,1,3,0)
 ;;=3^Band Keratopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,8791,1,4,0)
 ;;=4^H18.423
 ;;^UTILITY(U,$J,358.3,8791,2)
 ;;=^5005068
 ;;^UTILITY(U,$J,358.3,8792,0)
 ;;=H10.503^^41^468^19
 ;;^UTILITY(U,$J,358.3,8792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8792,1,3,0)
 ;;=3^Blepharoconjunctivitis,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,8792,1,4,0)
 ;;=4^H10.503
 ;;^UTILITY(U,$J,358.3,8792,2)
 ;;=^5004699
 ;;^UTILITY(U,$J,358.3,8793,0)
 ;;=H18.13^^41^468^23
 ;;^UTILITY(U,$J,358.3,8793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8793,1,3,0)
 ;;=3^Bullous Keratopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,8793,1,4,0)
 ;;=4^H18.13
 ;;^UTILITY(U,$J,358.3,8793,2)
 ;;=^5005034
 ;;^UTILITY(U,$J,358.3,8794,0)
 ;;=H17.13^^41^468^26
 ;;^UTILITY(U,$J,358.3,8794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8794,1,3,0)
 ;;=3^Central Corneal Opacity,Bilateral
 ;;^UTILITY(U,$J,358.3,8794,1,4,0)
 ;;=4^H17.13
 ;;^UTILITY(U,$J,358.3,8794,2)
 ;;=^5004993
 ;;^UTILITY(U,$J,358.3,8795,0)
 ;;=H16.013^^41^468^29
 ;;^UTILITY(U,$J,358.3,8795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8795,1,3,0)
 ;;=3^Central Corneal Ulcer,Bilateral
 ;;^UTILITY(U,$J,358.3,8795,1,4,0)
 ;;=4^H16.013
 ;;^UTILITY(U,$J,358.3,8795,2)
 ;;=^5004872
 ;;^UTILITY(U,$J,358.3,8796,0)
 ;;=H11.123^^41^468^32
 ;;^UTILITY(U,$J,358.3,8796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8796,1,3,0)
 ;;=3^Conjunctival Concretions,Bilateral
 ;;^UTILITY(U,$J,358.3,8796,1,4,0)
 ;;=4^H11.123
 ;;^UTILITY(U,$J,358.3,8796,2)
 ;;=^5004751
 ;;^UTILITY(U,$J,358.3,8797,0)
 ;;=H11.443^^41^468^35
 ;;^UTILITY(U,$J,358.3,8797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8797,1,3,0)
 ;;=3^Conjunctival Cysts,Bilateral
